These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1654375)

  • 41. The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity.
    Harmon SA; Richards OC; Summers DF; Ehrenfeld E
    J Virol; 1991 May; 65(5):2757-60. PubMed ID: 1850050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid and efficient purification of hepatitis A virus from cell culture.
    Bishop NE; Hugo DL; Borovec SV; Anderson DA
    J Virol Methods; 1994 Apr; 47(1-2):203-16. PubMed ID: 8051227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biophysical and biochemical characterization of hepatitis A virus.
    Coulepis AG; Locarnini SA; Westaway EG; Tannock GA; Gust ID
    Intervirology; 1982; 18(3):107-27. PubMed ID: 6292126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization and classification of virus particles associated with hepatitis A. III. Structural proteins.
    Tratschin JD; Siegl G; Frösner GG; Deinhardt F
    J Virol; 1981 Apr; 38(1):151-6. PubMed ID: 6264098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replicative events in hepatitis A virus-infected MRC-5 cells.
    De Chastonay J; Siegl G
    Virology; 1987 Apr; 157(2):268-75. PubMed ID: 3029972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propagation of hepatitis A virus in a renal cell line JTC-12.P3 of cynomolgus monkey origin.
    Baba M; Takegawa M; Kaito M; Miyamoto K; Suzuki S
    Acta Virol; 1993 Aug; 37(4):209-22. PubMed ID: 7905235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of infectious hepatitis A virus and its genome in artificial seawater.
    Arnal C; Crance JM; Gantzer C; Schwartzbrod L; Deloince R; Billaudel S
    Zentralbl Hyg Umweltmed; 1998 Sep; 201(3):279-84. PubMed ID: 9789362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of defective genomes in hepatitis A virus particles present in clinical specimens.
    Nüesch JP; de Chastonay J; Siegl G
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3475-80. PubMed ID: 2558163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small virus particles in faeces of patients with infectious hepatitis (hepatitis A).
    Skidmore SJ; Boxall EH
    J Med Microbiol; 1977 Feb; 10(1):43-8. PubMed ID: 190403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteolytic cleavage of VP1 in 'A' particles of coxsackievirus B3 does not appear to mediate virus uncoating by HeLa cells.
    McGeady ML; Crowell RL
    J Gen Virol; 1981 Aug; 55(Pt 2):439-50. PubMed ID: 6270273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein.
    Ostermayr R; von der Helm K; Gauss-Müller V; Winnacker EL; Deinhardt F
    J Virol; 1987 Nov; 61(11):3645-7. PubMed ID: 2822970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Echovirus 11 dense particles: isolation and preliminary characterization.
    Cova-Baczko L; Aymard M
    J Gen Virol; 1982 May; 60(Pt 1):159-63. PubMed ID: 7097249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiochemical and immunological characterization of hepatitis A virus nucleocapsids expressed in a vaccinia virus/T7/EMCV system.
    Zhu NL; Li GD; Wang Y
    Arch Virol; 1994; 135(3-4):443-9. PubMed ID: 7979980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus.
    Kusov YYu ; Kazachkov YA; Dzagurov GK; Khozinskaya GA; Balayan MS; Gauss-Müller V
    J Med Virol; 1992 Jul; 37(3):220-7. PubMed ID: 1331311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Separation and infectivity of two particle types of human rotavirus.
    Elias MM
    J Gen Virol; 1977 Oct; 37(1):191-4. PubMed ID: 199702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological and physicochemical characterization of the major (1.40) and minor (1.45) component of infectious avian adeno-associated virus.
    Bauer HJ; Schneider R; Gelderblom HR; Lurz R; Friehmelt V; Monreal G
    Arch Virol; 1991; 120(1-2):123-33. PubMed ID: 1656917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical and biological properties of dengue-2 virus and associated antigens.
    Smith TJ; Brandt WE; Swanson JL; McCown JM; Buescher EL
    J Virol; 1970 Apr; 5(4):524-32. PubMed ID: 4195055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical and biophysical characterization of light and heavy density hepatitis A virus particles: evidence HAV is an RNA virus.
    Bradley DW; Fields HA; McCaustland KA; Cook EH; Gravelle CR; Maynard JE
    J Med Virol; 1978; 2(2):175-87. PubMed ID: 27576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.